Copenhagen declaration: a blueprint for diabetes care and research in an interconnected world
Beyh YS, Bergman M, Chan JCN et al.
The Global Diabetes Forum (GDF). Pub. online 30 May 2025.
Leggi
Breaking news
Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association
Cusi K, Abdelmalek MF, Apovian CM, et al.
Diabetes Care. 2025:dci240094.
Leggi
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Mozaffarian D, Agarwal M, Aggarwal M, et al.
Obesity (Silver Spring). Pub. online 30 May 2025.
Leggi
Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy
Martinenghi S, Merolla A, Grogan P, et al.
Diabetologia. Pub. online 29 May 2025.
Leggi
Initiation of continuous glucose monitoring and mortality in type 2 diabetes
Reaven PD, Macwan S, Newell M, et al.
Diabetes Technol Ther. Pub. online 28 May 2025.
Leggi
Once-weekly mazdutide in chinese adults with obesity or overweight
Ji L, Jiang H, Bi Y, et al.
N Engl J Med. Pub. online 25 May 2025.
Leggi
The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: a real-world retrospective cohort study
Haughton S, Riley D, Berry S, et al.
Diabetes Obes Metab. Pub. online 19 May 2025.
Leggi
In utero exposure to maternal hyperglycemia and offspring type 2 diabetes genetic risk score are independently associated with risk of impaired glucose tolerance in youth
Dieguez AC, Kuang A, Josefson JL, et al.
Diabetes Care. 2025:dc242891.
Leggi
Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE randomized clinical trial
Luchsinger JA, Rosin SP, Kazemi EJ, et al.
JAMA Intern Med. 2025:e251189.
Leggi
An exploratory cost-effectiveness analysis of immune therapy in delaying the initiation of automated insulin delivery systems in type 1 diabetes
Mital S, Haller MJ, Schatz DA, Nguyen HV
Diabetes Technol Ther. Pub. online 12 May 2025.
Leggi